UBTD2-SH3PXD2B Fusion FISH Probe
The UBTD2-SH3PXD2B Fusion FISH Probe is used to confirm a fusion of the UBTD2 and SH3PXD2B genes. The fusion of the UBTD2 and SH3PXD2B genes has been associated with Breast Invasive Carcinoma, and Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| UBTD2-SH3PXD2B-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| UBTD2-SH3PXD2B-20-RERE | 20 (40 μL) | 200 μL |
|
|
| UBTD2-SH3PXD2B-20-REOR | 20 (40 μL) | 200 μL |
|
|
| UBTD2-SH3PXD2B-20-REGO | 20 (40 μL) | 200 μL |
|
|
| UBTD2-SH3PXD2B-20-REGR | 20 (40 μL) | 200 μL |
|
|
| UBTD2-SH3PXD2B-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| UBTD2-SH3PXD2B-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| UBTD2-SH3PXD2B-20-OROR | 20 (40 μL) | 200 μL |
|
|
| UBTD2-SH3PXD2B-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| UBTD2-SH3PXD2B-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| UBTD2-SH3PXD2B-20-GORE | 20 (40 μL) | 200 μL |
|
|
| UBTD2-SH3PXD2B-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| UBTD2-SH3PXD2B-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| UBTD2-SH3PXD2B-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| UBTD2-SH3PXD2B-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| UBTD2-SH3PXD2B-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| UBTD2-SH3PXD2B-20-GROR | 20 (40 μL) | 200 μL |
|
|
| UBTD2-SH3PXD2B-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| UBTD2-SH3PXD2B-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| UBTD2-SH3PXD2B-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| UBTD2-SH3PXD2B-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| UBTD2-SH3PXD2B-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| UBTD2-SH3PXD2B-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| UBTD2-SH3PXD2B-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| UBTD2-SH3PXD2B-20-AQAQ | 20 (40 μL) | 200 μL |
|
UBTD2 Gene Summary
The Ubiquitin Domain Containing 2 (UBTD2) gene is located on chr5 :171636649-171710795 at 5q35.1.
Gene Name: Ubiquitin Domain Containing 2
Chromosome: CHR5: 171636649 -171710795
Locus: 5q35.1
SH3PXD2B Gene Summary
This gene encodes an adapter protein that is characterized by a PX domain and four Src homology 3 domains. The encoded protein is required for podosome formation and is involved in cell adhesion and migration of numerous cell types. Mutations in this gene are the cause of Frank-ter Haar syndrome (FTHS), and also Borrone Dermato-Cardio-Skeletal (BDCS) syndrome. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Apr 2015]
Gene Name: SH3 And PX Domains 2B
Chromosome: CHR5: 171760502 -171881527
Locus: 5q35.1
Gene Diseases
The UBTD2 SH3PXD2B Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
| Bladder Urothelial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|